Human Genome Epidemiology Literature Finder
Records 1 - 13 (of 13 Records) |
Query Trace: Neoplasms and FGF4[original query] |
---|
Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing. Oncotarget 2014 May 5 (10): 3012-22. Janku Filip, Kaseb Ahmed O, Tsimberidou Apostolia M, Wolff Robert A, Kurzrock Razel |
Unique molecular signatures as a hallmark of patients with metastatic breast cancer: implications for current treatment paradigms. Oncotarget 2014 May 5 (9): 2349-54. Wheler Jennifer J, Parker Barbara A, Lee Jack J, Atkins Johnique T, Janku Filip, Tsimberidou Apostolia M, Zinner Ralph, Subbiah Vivek, Fu Siqing, Schwab Richard, Moulder Stacy, Valero Vicente, Schwaederle Maria, Yelensky Roman, Miller Vincent A, Stephens M Philip J, Meric-Bernstam Funda, Kurzrock Razel |
Fibroblast growth factor family aberrations in cancers: clinical and molecular characteristics. Cell cycle (Georgetown, Tex.) 2015 14 (13): 2121-8. Parish A, Schwaederle M, Daniels G, Piccioni D, Fanta P, Schwab R, Shimabukuro K, Parker B A, Helsten T, Kurzrock |
Clinical Utility of Cerebrospinal Fluid Cell-Free DNA as Liquid Biopsy for Leptomeningeal Metastases in ALK-Rearranged NSCLC. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2019 Jan . Zheng Mei-Mei, Li Yang-Si, Jiang Ben-Yuan, Tu Hai-Yan, Tang Wen-Fang, Yang Jin-Ji, Zhang Xu-Chao, Ye Jun-Yi, Yan Hong-Hong, Su Jian, Zhou Qing, Zhong Wen-Zhao, Yang Xue-Ning, Guo Wei-Bang, Chuai Shannon, Zhang Zhou, Chen Hua-Jun, Wang Zhen, Liu Chao, Wu Yi-Lo |
Characterizations of Cancer Gene Mutations in Chinese Metastatic Breast Cancer Patients. Frontiers in oncology 2020 7 10 1023. Tao Zhonghua, Li Ting, Feng Zhe, Liu Chang, Shao Yilin, Zhu Mingyu, Gong Chengcheng, Wang Biyun, Cao Jun, Wang Leipin, Du Yiqun, Lizaso Analyn, Li Bing, Zhang Jian, Hu Xich |
Mutational Characterization and Potential Prognostic Biomarkers of Chinese Patients with Esophageal Squamous Cell Carcinoma. OncoTargets and therapy 2020 13 12797-12809. Zhang Nan, Shi Junping, Shi Xiaoliang, Chen Wenting, Liu Junfe |
Unique genomic features and prognostic value of COSMIC mutational signature 4 in lung adenocarcinoma and lung squamous cell carcinoma. Annals of translational medicine 2020 11 8 (18): 1176. Cai Xiuyu, Chen Zhenghe, Deng Meiling, Li Zhiyong, Wu Qianchao, Wei Jinwang, Dai Chun, Wang Guan, Luo Ch |
Amplification of the human epidermal growth factor receptor 2 (HER2) gene is associated with a microsatellite stable status in Chinese gastric cancer patients. Journal of gastrointestinal oncology 2021 Apr 12 (2): 377-387. Huang He, Wang Zhengkun, Li Yi, Zhao Qun, Niu Zhaoji |
The emergence of various genetic alterations mediated the Osimertinib resistance of a patient harboring heterozygous germline EGFR T790M: a case report. Annals of translational medicine 2021 2 9 (1): 80. Liu Bin, Qin Jianwen, Yin Yan, Zhai Liang, Liu Guangxin, Lizaso Analyn, Shi Dongshe |
Prognostic biomarker study in patients with clinical stage I esophageal squamous cell carcinoma: JCOG0502-A1. Cancer science 2021 12 113 (3): 1018-1027. Oshima Kotoe, Kato Ken, Ito Yoshinori, Daiko Hiroyuki, Nozaki Isao, Nakagawa Satoru, Shibuya Yuichi, Kojima Takashi, Toh Yasushi, Okada Morihito, Hironaka Shuichi, Akiyama Yuji, Komatsu Yoshito, Maejima Kazuhiro, Nakagawa Hidewaki, Onuki Ritsuko, Nagai Momoko, Kato Mamoru, Kanato Keisuke, Kuchiba Aya, Nakamura Kenichi, Kitagawa Yu |
Gene alternation of cerebrospinal fluid in patients with leptomeningeal metastases of lung adenocarcinoma using next-generation sequencing. BMC cancer 2022 May 22 (1): 580. Yang Hainan, Wen Lei, Pan Yingying, Shan Changguo, Hong Weiping, Wang Hui, Zhou Cheng, Cai Linbo, Zhou Caic |
Gene Mutations Associated With Clinical Characteristics in the Tumors of Patients With Breast Cancer. Frontiers in oncology 2022 12 778511. Hao Chunfang, Wang Chen, Lu Ning, Zhao Weipeng, Li Shufen, Zhang Li, Meng Wenjing, Wang Shuling, Tong Zhongsheng, Zeng Yanwu, Lu Leil |
Racial Disparities in Pathological Complete Response Among Patients Receiving Neoadjuvant Chemotherapy for Early-Stage Breast Cancer. JAMA network open 2023 3 6 (3): e233329. Zhao Fangyuan, Miyashita Minoru, Hattori Masaya, Yoshimatsu Toshio, Howard Frederick, Kaneva Kristiyana, Jones Ryan, Bell Joshua S K, Fleming Gini F, Jaskowiak Nora, Nanda Rita, Zheng Yonglan, Huo Dezheng, Olopade Olufunmilayo |
- Page last reviewed:Feb 1, 2024
- Content source: